Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Open accessPublished version of a preprint
The DOI matches its Crossref record; 102 of the 103 references it cites were found in a registry or an index.
Abstract
In recent years evidence has emerged that neurodegenerative diseases (NDs) are strongly associated with the microbiome composition in the gut. Parkinson’s disease (PD) is the most intensively studied neurodegenerative disease in this context. In this review, we performed a systematic evaluation of the published literature comparing changes in colonic microbiome in PD to the ones observed in other NDs including Alzheimer’s disease (AD), multiple system atrophy (MSA), multiple sclerosis (MS), neuromyelitis optica (NMO) and amyotrophic lateral sclerosis (ALS). To enhance the comparability of different studies, only human case-control studies were included. Several studies showed an increase of Lactobacillus, Bifidobacterium, Verrucomicrobiaceae and Akkermansia in PD. A decrease of Faecalibacterium spp., Coprococcus spp., Blautia spp., Prevotella spp. and Prevotellaceae was observed in PD. On a low taxonomic resolution, like the phylum level, the changes are not disease-specific and are inconsistent. However, on a higher taxonomic resolution like genus or species level, a minor overlap was observed between PD and MSA, both alpha synucleinopathies. We show that standardization of sample collection and analysis is necessary for ensuring the reproducibility and comparability of data. We also provide evidence that assessing the microbiota composition at high taxonomic resolution reveals changes in relative abundance that may be specific to or characteristic of one disease or disease group, and might evolve discriminative power. The interactions between bacterial species and strains and the co-abundances must be investigated before assumptions about the effects of specific bacteria on the host can be made with certainty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Akkermansia utilize mucin as a source of energy and may therefore reduce barrier function and increase exposure to more microbial substrates across the epithelial lining.44”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“There are up to 100 times more microbial genes, named the microbiome, than human genes in one individual [7].”
BackgroundKalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Human Genetics Shape the Gut Microbiome
Goodrich, J. K., Waters, J. L., Poole, A. C., Sutter, J. L., Koren, O., Blekhman, R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.053 · Cited by 3,164 · cited 1×
“Since the Faecalibacterium prausnitzi species include a high diversity of strains, a strain-dependent classification and investigation would improve insight into the beneficial and harmful effects on the host [79].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137 · cited 2×
“Other methodical choices, like choosing between the different bead beating cell lysis instruments before metagenome analysis, influence this ratio up to threefold in favour of Bacteroides [55].”
BackgroundAre We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Sender, R., Fuchs, S., & Milo, R. (2016) · Cell · doi:10.1016/j.cell.2016.01.013 · Cited by 2,050
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Research works printed but not linked: 1
- He Z. Microarrays Caister Academic Press Wymondham, UK 2014
Cited by
Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine
Kayama, H., Okumura, R., & Takeda, K. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-070119-115104 · Cited by 747
Role and Mechanism of Gut Microbiota in Human Disease
Chen, Y., Zhou, J., & Wang, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.625913 · Cited by 627
Zhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616
Facchin, S., Bertin, L., Bonazzi, E., Lorenzon, G., De Barba, C., Barberio, B., Zingone, F., Maniero, D., Scarpa, M., Ruffolo, C., et al. (2024) · Life · doi:10.3390/life14050559 · Cited by 380
“The lowered SCFAs-mediated secretion of GLP-1 may activate pro-inflammatory pathways and depressive symptoms in PD patients [210,211].”
BackgroundProbiotics, prebiotics, and postbiotics in health and disease
Ji, J., Jin, W., Liu, S., Jiao, Z., & Li, X. (2023) · MedComm · doi:10.1002/mco2.420 · Cited by 384
“51,52 Although current research presents some varied results, each bacterial group in the gut plays specific roles.”
BackgroundThe Association between Early-Life Gut Microbiota and Long-Term Health and Diseases
Sarkar, A., Yoo, J. Y., Valeria Ozorio Dutra, S., Morgan, K. H., & Groer, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030459 · Cited by 342
“Elucidating the functional mechanisms for these correlations, and possible causal relationships, will allow identification of targets for early diagnosis, intervention, therapeutics, and possibly prevention [171].”
BackgroundRole of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A., & Covasa, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020436 · Cited by 307
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Sun, J., Li, H., Jin, Y., Yu, J., Mao, S., Su, K.-P., Ling, Z., & Liu, J. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.10.014 · Cited by 264
Wallen, Z. D., Appah, M., Dean, M. N., Sesler, C. L., Factor, S. A., Molho, E., Zabetian, C. P., Standaert, D. G., & Payami, H. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-0112-6 · Cited by 252
The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., et al. (2022) · Nutrients · doi:10.3390/nu14030668 · Cited by 225
Aging, Frailty, and the Microbiome—How Dysbiosis Influences Human Aging and Disease
Haran, J. P., & McCormick, B. A. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.060 · Cited by 216
Gut bacterial profiles in Parkinson's disease: A systematic review
Li, Z., Liang, H., Hu, Y., Lu, L., Zheng, C., Fan, Y., Wu, B., Zou, T., Luo, X., Zhang, X., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13990 · Cited by 206
The Role of Gut Bacterial Metabolites in Brain Development, Aging and Disease
Tran, S. M.-S., & Mohajeri, M. H. (2021) · Nutrients · doi:10.3390/nu13030732 · Cited by 210
“Furthermore, our collected data on indole and indole derivatives show correlations with various brain disorders (autism, anxiety, PD) that are often accompanied with gut issues [36,110,132,181].”
BackgroundResultSelf-citationGuild-based analysis for understanding gut microbiome in human health and diseases
Wu, G., Zhao, N., Zhang, C., Lam, Y. Y., & Zhao, L. (2021) · Genome Medicine · doi:10.1186/s13073-021-00840-y · Cited by 203
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Li, J., Zheng, M., Shimoni, O., Banks, W. A., Bush, A. I., Gamble, J. R., & Shi, B. (2021) · Advanced Science · doi:10.1002/advs.202101090 · Cited by 202
Wasser, C. I., Mercieca, E.-C., Kong, G., Hannan, A. J., McKeown, S. J., Glikmann-Johnston, Y., & Stout, J. C. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa110 · Cited by 198
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
Klann, E. M., Dissanayake, U., Gurrala, A., Farrer, M., Shukla, A. W., Ramirez-Zamora, A., Mai, V., & Vedam-Mai, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.782082 · Cited by 182
“…abundance of potentially detrimental bacteria, can compromise gut barrier integrity through bacterial production of endotoxins (e.g., lipopolysaccharide) capable of altering immune response, initiating proinflammatory pathways, and directly damaging intestinal epithelial cells (Ghosh et al., 2020).”
BackgroundBoertien, J. M., Pereira, P. A. B., Aho, V. T. E., & Scheperjans, F. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191711 · Cited by 170
“Changes in gut microbiome composition have been described in various neurodegenerative disorders, of which PD has been studied most extensively [11].”
BackgroundKandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022) · Metabolites · doi:10.3390/metabo12111064 · Cited by 159
Parkinson’s Disease and the Gastrointestinal Microbiome
Lubomski, M., Tan, A. H., Lim, S.-Y., Holmes, A. J., Davis, R. L., & Sue, C. M. (2020) · Journal of Neurology · doi:10.1007/s00415-019-09320-1 · Cited by 172
“After smoking cessation, a decreased abundance of Proteobacteria and an increased abundance of Firmicutes and Actinobacteria were observed [112].”
BackgroundInfluentialThe Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke
Chidambaram, S. B., Rathipriya, A. G., Mahalakshmi, A. M., Sharma, S., Hediyal, T. A., Ray, B., Sunanda, T., Rungratanawanich, W., Kashyap, R. S., Qoronfleh, M. W., et al. (2022) · Cells · doi:10.3390/cells11071239 · Cited by 160
“Henceforth, the gut microbiome has recently been emerged as a new important “organ” of the human organism [24,25], as it can influence the early stages of neural, immune, and metabolic abnormalities and pathologies [16,26–28].”
BackgroundRosario, D., Bidkhori, G., Lee, S., Bedarf, J., Hildebrand, F., Le Chatelier, E., Uhlen, M., Ehrlich, S. D., Proctor, G., Wüllner, U., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108807 · Cited by 167
Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
Ren, X., & Chen, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.602697 · Cited by 178
Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models
Castelli, V., d’Angelo, M., Lombardi, F., Alfonsetti, M., Antonosante, A., Catanesi, M., Benedetti, E., Palumbo, P., Cifone, M. G., Giordano, A., et al. (2020) · Aging · doi:10.18632/aging.102927 · Cited by 162
Short-chain fatty acids-producing probiotics: A novel source of psychobiotics
Cheng, Y., Liu, J., & Ling, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1920884 · Cited by 168
“…and depletion of bacteria belonging to the Lachnospiraceae family and the Faecalibacterium genus, both important SCFAs producers (mainly butyrate), emerged as the most consistent PD gut microbiome alterations (Keshavarzian et al. 2015; Gerhardt and Mohajeri 2018; Romano et al. 2021).”
BackgroundThe Contribution of Gut Microbiota–Brain Axis in the Development of Brain Disorders
Maiuolo, J., Gliozzi, M., Musolino, V., Carresi, C., Scarano, F., Nucera, S., Scicchitano, M., Oppedisano, F., Bosco, F., Ruga, S., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.616883 · Cited by 163
“In particular, significantly decreased Clostridium leptum and Clostridium saccharolyticum were observed in AD as well as an increased Bacteroidetes phylum and Alistipes genus (Gerhardt and Mohajeri, 2018).”
BackgroundEicher, T. P., & Mohajeri, M. H. (2022) · Nutrients · doi:10.3390/nu14132661 · Cited by 142
Self-citationRoles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 143
“A decrease in Faecalibacterium, Coprococcus, Blautia, and Prevotella abundance was also observed in PD (Gerhardt and Mohajeri, 2018).”
BackgroundBlood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 139
Inflammatory bowel diseases and Parkinson's disease
Brudek, T. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191729 · Cited by 139
Zhao, Z., Li, F., Ning, J., Peng, R., Shang, J., Liu, H., Shang, M., Bao, X.-Q., & Zhang, D. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.020 · Cited by 137
Bicknell, B. T., Liebert, A. D., Borody, T. J., Herkes, G., McLachlan, C. S., & Kiat, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119577 · Cited by 147
“Few studies have assessed the microbiome in MSA.”
BackgroundInfluentialThe gut-brain vascular axis in neuroinflammation
Carloni, S., & Rescigno, M. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101802 · Cited by 139
Chen, C., Wang, G., Li, D., & Zhang, F. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00307-1 · Cited by 147
“Increased Enterobacteriaceae (a family that includes endotoxin-producing Gram-negatives) has also been reported and was correlated with the severity of postural instability and gait difficulty in one study [157].”
Bioactive Polyphenols and Neuromodulation: Molecular Mechanisms in Neurodegeneration
Meo, F. D., Valentino, A., Petillo, O., Peluso, G., Filosa, S., & Crispi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072564 · Cited by 141
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
Baizabal-Carvallo, J. F., & Alonso-Juarez, M. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.030 · Cited by 130
Bhattarai, Y., Si, J., Pu, M., Ross, O. A., McLean, P. J., Till, L., Moor, W., Grover, M., Kandimalla, K. K., Margolis, K. G., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1866974 · Cited by 126
Knuesel, T., & Mohajeri, M. H. (2021) · Nutrients · doi:10.3390/nu14010037 · Cited by 109
“A disturbed intestinal microbiota, often associated with reduced diversity, was found in a variety of diseases, including hypertension [13], obesity [14], gastrointestinal disorders (such as inflammatory bowel disease (IBD) [15,16], and IBS [17]), brain disorders (such as Alzheimer’s disease [18], Parkinson’s disease…”
BackgroundSelf-citationHegelmaier, T., Lebbing, M., Duscha, A., Tomaske, L., Tönges, L., Holm, J. B., Bjørn Nielsen, H., Gatermann, S. G., Przuntek, H., & Haghikia, A. (2020) · Cells · doi:10.3390/cells9020376 · Cited by 118
“Many speci s of the phylum can pr duc folate [49].”
BackgroundThe Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
Kirby, T. O., & Ochoa‐Repáraz, J. (2018) · Medical Sciences · doi:10.3390/medsci6030069 · Cited by 128
Shobeiri, P., Kalantari, A., Teixeira, A. L., & Rezaei, N. (2022) · Biology of Sex Differences · doi:10.1186/s13293-022-00422-6 · Cited by 124
Gut Microbiota Interaction with the Central Nervous System throughout Life
Ojeda, J., Ávila, A., & Vidal, P. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061299 · Cited by 103
The Potential Influence of the Bacterial Microbiome on the Development and Progression of ADHD
Bull-Larsen, S., & Mohajeri, M. H. (2019) · Nutrients · doi:10.3390/nu11112805 · Cited by 106
“Research highlights this risk, as gut dysbiosis in child or adulthood has not only been associated with various diseases, such as irritable bowel syndrome [6] or obesity [7], but also with psychiatric disorders as, for example, depression [8], Parkinson′s disease (PD) [9], schizophrenia [10], autism spectrum disorder…”
BackgroundSelf-citationGerm-free animal experiments in the gut microbiota studies
Uzbay, T. I. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.03.016 · Cited by 117
Nutritional Risk Factors, Microbiota and Parkinson’s Disease: What Is the Current Evidence?
Boulos, C., Yaghi, N., El Hayeck, R., Heraoui, G. N., & Fakhoury-Sayegh, N. (2019) · Nutrients · doi:10.3390/nu11081896 · Cited by 109
“No studies reported any significant differences in the Firmicutes to Bacteroidetes ratio in PD patients [137].”
BackgroundInfluentialKawashima, Y., Watanabe, E., Umeyama, T., Nakajima, D., Hattori, M., Honda, K., & Ohara, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235932 · Cited by 114
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Ahmed, S., Busetti, A., Fotiadou, P., Vincy Jose, N., Reid, S., Georgieva, M., Brown, S., Dunbar, H., Beurket-Ascencio, G., Delday, M. I., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00402 · Cited by 98
“Alterations of the microbiota composition in neurodegenerative diseases including PD and AD have been well documented (Gerhardt and Mohajeri, 2018; Sun and Shen, 2018).”
BackgroundButler, M., Mörkl, S., Sandhu, K. V., Cryan, J. F., & Dinan, T. G. (2019) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719874168 · Cited by 117
“Several studies showed an increase of Lactobacillus, Bifidobacterium, Akkermansia, and Verrucomicrobiaceae in PD, while Faecalibacterium, Coprococcus, Blautia, and Prevotella appear to be underrepresented.(94) Conversely, Bifidobacterium appears to be decreased in AD.”
ResultMihaila, D., Donegan, J., Barns, S., LaRocca, D., Du, Q., Zheng, D., Vidal, M., Neville, C., Uhlig, R., & Middleton, F. A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0218252 · Cited by 94
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Lin, X., Zhao, J., Zhang, W., He, L., Wang, L., Chang, D., Cui, L., Gao, Y., Li, B., Chen, C., et al. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.110130 · Cited by 93
Diet and the gut microbiome in patients with Parkinson’s disease
Kwon, D., Zhang, K., Paul, K. C., Folle, A. D., Del Rosario, I., Jacobs, J. P., Keener, A. M., Bronstein, J. M., & Ritz, B. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00681-7 · Cited by 86
“Additionally, we observed that a higher fi ber intake was associated with a decrease in the pro-in fl ammatory bacteria, Bacteroides , which have been found to be elevated in PD patients compared to controls 12,27 – 29 .”
Sex Differences in the Gut-Brain Axis: Implications for Mental Health
Holingue, C., Budavari, A. C., Rodriguez, K. M., Zisman, C. R., Windheim, G., & Fallin, M. D. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01202-y · Cited by 85
Microbiome, Parkinson’s Disease and Molecular Mimicry
Miraglia, F., & Colla, E. (2019) · Cells · doi:10.3390/cells8030222 · Cited by 90
“Because a healthy intestinal development requires microbiota colonization and robust antibiotic treatments can also influence the host physiology [99], data on GF animals should be taken cautiously, and such massive effects should be first investigated for their relevance to their host’s physiology.”
BackgroundLi, Y., Shao, L., Mou, Y., Zhang, Y., & Ping, Y. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1957407 · Cited by 86
“It has been suggested that α-diversity analysis and Firmicutes/Bacteroidetes (F/B) ratio, two frequently used criteria in microbiome analysis, are not reliable in investigating the association between GM alteration and PD.(6,39) Interestingly, we also found inconsistent results of α-diversity, F/B ratio and GM changes…”
BackgroundMethodResultInfluentialProbiotics for Neurodegenerative Diseases: A Systemic Review
Ojha, S., Patil, N., Jain, M., Kole, C., & Kaushik, P. (2023) · Microorganisms · doi:10.3390/microorganisms11041083 · Cited by 88
Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease
Huang, Y., Liao, J., Liu, X., Zhong, Y., Cai, X., & Long, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.615075 · Cited by 75
Yu, L., Hu, X., Xu, R., Zhao, Y., Xiong, L., Ai, J., Wang, X., Chen, X., Ba, Y., Xing, Z., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117628 · Cited by 84
Bazzocchi, G., Turroni, S., Bulzamini, M. C., D’Amico, F., Bava, A., Castiglioni, M., Cagnetta, V., Losavio, E., Cazzaniga, M., Terenghi, L., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92027-z · Cited by 86
Microbiome as an immune regulator in health, disease, and therapeutics
Juarez, V. M., Montalbine, A. N., & Singh, A. K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114400 · Cited by 79
Can infections trigger alpha-synucleinopathies?
Tulisiak, C. T., Mercado, G., Peelaerts, W., Brundin, L., & Brundin, P. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.002 · Cited by 80
Dong, X.-L., Wang, X., Liu, F., Liu, X., Du, Z.-R., Li, R. W., Xue, C.-H., Wong, K.-H., Wong, W.-T., Zhao, Q., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.180 · Cited by 75
Lei, Q., Wu, T., Wu, J., Hu, X., Guan, Y., Wang, Y., Yan, J., & Shi, G. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12374 · Cited by 80
dos Santos, J. C. C., Oliveira, L. F., Noleto, F. M., Gusmão, C. T. P., Brito, G. A. D. C., & Viana, G. S. D. B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373673 · Cited by 76
“A number of studies have reported consistently higher abundances of phyla Actinobacteria and Verrucomicrobia, and lower abundances of phyla Firmicutes and Bacteroides, as being of importance for PD (Scheperjans et al., 2015; Bedarf et al., 2017; Petrov et al., 2017; Gerhardt and Mohajeri, 2018).”
MethodResultBacterially produced metabolites protect C. elegans neurons from degeneration
Urrutia, A., García-Angulo, V. A., Fuentes, A., Caneo, M., Legüe, M., Urquiza, S., Delgado, S. E., Ugalde, J., Burdisso, P., & Calixto, A. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000638 · Cited by 71
Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota
Yemula, N., Dietrich, C. M., Dostal, V., & Hornberger, M. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212707 · Cited by 75
Aljeradat, B., Kumar, D., Abdulmuizz, S., Kundu, M., Almealawy, Y. F., Batarseh, D. R., Atallah, O., Ennabe, M., Alsarafandi, M., Alan, A., et al. (2024) · Pathophysiology · doi:10.3390/pathophysiology31020019 · Cited by 76
“Alterations of the colon’s components have also been established to be related to Parkinson’s disease and other neurodegenerative diseases, according to a meta-analysis carried out by Gerhardt and colleagues [61].”
BackgroundWallen, Z. D. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04193-6 · Cited by 76
“This group included genera previously associated with PD such as Bifidobacterium, Lactobacillus, and short-chain fatty-acid producing bacteria Faecalibacterium, Roseburia, Blautia, and other members of the Ruminococcaceae and Lachnospiraceae family [22, 23].”
BackgroundLorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69
“Its abundance in the human intestinal tract is inversely correlated to several disease states such as obesity [132–134], while an increase of the relative abundance is consistently reported in PD patients [49,135].”
BackgroundGut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model
Sun, B.-L., Li, W.-W., Wang, J., Xu, Y.-L., Sun, H.-L., Tian, D.-Y., Wang, Y.-J., & Yao, X.-Q. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181220 · Cited by 66
“According to a previous report, the relative abundance of Bac-teroidetes decreased in patients with AD [30].”
Role of environmental factors in multiple sclerosis
Zarghami, A., Li, Y., Claflin, S. B., van der Mei, I. A. F., & Taylor, B. V. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1978843 · Cited by 74
Rosario, D., Boren, J., Uhlen, M., Proctor, G., Aarsland, D., Mardinoglu, A., & Shoaie, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00716 · Cited by 67
“Interactions happening between transcription factors and genes are represented in GRNs. Based on transcriptional regulatory network principles, GRNs highlight the control of spatiotemporal gene expression (Gerstein et al., 2012).”
BackgroundYue, M., Wei, J., Chen, W., Hong, D., Chen, T., & Fang, X. (2022) · Nutrients · doi:10.3390/nu14224886 · Cited by 62
“The role of Akkermansia is not yet clear but maintaining constancy of Akkermansia may be a prerequisite for gut physiological functioning [50].”
BackgroundKim, S., Park, S., Choi, T. G., & Kim, S. S. (2022) · Nutrients · doi:10.3390/nu14142982 · Cited by 70
The contribution of age-related changes in the gut-brain axis to neurological disorders
Khan, R., Gesù, C. M. D., Lee, J., & McCullough, L. D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2302801 · Cited by 63
“Increases in Proteus mirabilis are also linked to PD symptoms and have been shown to promote motor deficits in mouse models of PD. 139 Researchers have linked the changes in the expression of these specific bacterial genes to mechanisms that regulate lipid biosynthesis and secretory pathways, including dopamine (DA) r…”
BackgroundInfluentialVidal-Martinez, G., Chin, B., Camarillo, C., Herrera, G. V., Yang, B., Sarosiek, I., & Perez, R. G. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191693 · Cited by 57
“0172) compared to controls, consistent with the results of others [40, 42].”
ResultWalker, A. C., Bhargava, R., Vaziriyan-Sani, A. S., Pourciau, C., Donahue, E. T., Dove, A. S., Gebhardt, M. J., Ellward, G. L., Romeo, T., & Czyż, D. M. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009510 · Cited by 62
The role of nutrition on Parkinson’s disease: a systematic review
Bianchi, V. E., Rizzi, L., & Somaa, F. A. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2073107 · Cited by 66
“in Faecalibacterium, Coprococcus, Blautia, Prevotella, and Prevotellaceae within PD patients [209].”
BackgroundWu, H., Wei, J., Zhao, X., Liu, Y., Chen, Z., Wei, K., Lu, J., Chen, W., Jiang, M., Li, S., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10351 · Cited by 63
Gan, Q., Peng, M., Wei, H., Chen, L., Chen, X.-Y., Li, Z.-H., An, G., & Ma, Y. (2024) · Food & Function · doi:10.1039/d3fo05169b · Cited by 59
Chen, S.-J., Chen, C.-C., Liao, H.-Y., Wu, Y.-W., Liou, J.-M., Wu, M.-S., Kuo, C.-H., & Lin, C.-H. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223179 · Cited by 55
Microbiota of the gastrointestinal tract: Friend or foe?
Senchukova, M. A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i1.19 · Cited by 61
Wang, N., Feng, B., Hu, B., Cheng, Y., Guo, Y., & Qian, H. (2021) · Food & Function · doi:10.1039/d1fo02216d · Cited by 56
Urolithins: Potential Biomarkers of Gut Dysbiosis and Disease Stage in Parkinson’s Patients
Romo-Vaquero, M., Fernández-Villalba, E., Gil-Martinez, A.-L., Cuenca-Bermejo, L., Espín, J. C., Herrero, M. T., & Selma, M. V. (2022) · Food & Function · doi:10.1039/d2fo00552b · Cited by 54
Kohnert, E., Kreutz, C., Binder, N., Hannibal, L., Gorkiewicz, G., Müller, A., Storz, M. A., Huber, R., & Lederer, A. (2021) · Microorganisms · doi:10.3390/microorganisms9040727 · Cited by 55
“Coprococcus is also reported to be depleted in neurodegenerative disorders such as Parkinson’s disease [48].”
BackgroundTargeting gut microbiota to alleviate neuroinflammation in Alzheimer’s disease
Nguyen, V. T. T., & Endres, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114418 · Cited by 60
Lin, X., Zhao, J., Zhang, W., He, L., Wang, L., Li, H., Liu, Q., Cui, L., Gao, Y., Chen, C., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124923 · Cited by 58
Fakhri, S., Yarmohammadi, A., Yarmohammadi, M., Farzaei, M. H., & Echeverría, J. (2021) · Marine Drugs · doi:10.3390/md19030165 · Cited by 57
“The PD metagenome includes more levels of genes taking part in LPS biosynthesis and type 3 bacterial secretion systems which show the higher potential of inflammation by microbial metabolites [57].”
BackgroundVoigt, R. M., Wang, Z., Brown, J. M., Engen, P. A., Naqib, A., Goetz, C. G., Hall, D. A., Metman, L. V., Shaikh, M., Forsyth, C. B., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105780 · Cited by 51
“, shift in Firmicute / Bacteroidetes ratio) (Keshavarzian et al., 2015; Sun and Shen, 2018; Li et al., 2021; Unger et al., 2016; Nuzum et al., 2020; Bullich et al., 2019; Gerhardt and Mohajeri, 2018; Lin et al., 2019).”
Brown, T., Sykes, D., & Allen, A. R. (2021) · Biomedicines · doi:10.3390/biomedicines9020189 · Cited by 54
Xia, Y., Zhu, J., Xu, Y., Zhang, H., Zou, F., & Meng, X. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.127220 · Cited by 51
What Is the Evidence that Parkinson’s Disease Is a Prion Disorder, Which Originates in the Gut?
Kujawska, M., & Jodynis‐Liebert, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113573 · Cited by 51
“A systematic review by Gerhardt and Mohajeri [43] have summarized the findings on the composition of fecal or intestinal Fig re 1.”
BackgroundInfluentialYadav, H., Jaldhi, Bhardwaj, R., Anamika, A., Bakshi, A., Gupta, S., & Maurya, S. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122022 · Cited by 52
Role of Gut Microbiota in Combating Oxidative Stress
Dam, B., Misra, A., & Banerjee, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-8763-0_4 · Cited by 49
Gut microbiota as a potential player in mn-induced neurotoxicity
Tinkov, A. A., Martins, A. C., Avila, D. S., Gritsenko, V. A., Skalny, A. V., Santamaria, A., Lee, E., Bowman, A. B., & Aschner, M. (2021) · Biomolecules · doi:10.3390/biom11091292 · Cited by 45
Yousefi, B., Kokhaei, P., Mehranfar, F., Bahar, A., Abdolshahi, A., Emadi, A., & Eslami, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.046 · Cited by 51
The sex-specific interaction of the microbiome in neurodegenerative diseases
Cox, L. M., Abou-El-Hassan, H., Maghzi, A. H., Vincentini, J., & Weiner, H. L. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146385 · Cited by 42
Gut Microbiota: Critical Controller and Intervention Target in Brain Aging and Cognitive Impairment
Li, H., Ni, J., & Qing, H. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.671142 · Cited by 47
Metadata
- Authors
- Gerhardt, S., & Mohajeri, M. H.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Mohajeri, M. Hasan
- ORCID
- Mohajeri, M. Hasan
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-06-01
- Volume
- 10
- Issue
- 6
- Pages
- 708
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC6024871
- OpenAlex
- W2800577687
- Cited by
- 298
- References
- 103
- Citations by year
- 2026: 18 · 2025: 19 · 2024: 35 · 2023: 41 · 2022: 46 · 2021: 70 · 2020: 36 · 2019: 29 · 2018: 3
- FWCI
- 3.38
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Multiple Sclerosis Society
- EU Joint Programme – Neurodegenerative Disease Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Parkinson's disease, gut microbiota, colonic microbiota, neurodegenerative diseases, Alzheimer's disease, multiple system atrophy, multiple sclerosis, neuromyelitis optica, amyotrophic lateral sclerosis, Lactobacillus, Bifidobacterium, Akkermansia, Verrucomicrobiaceae, Faecalibacterium, Prevotella, synucleinopathies
- MeSH terms
- Gastrointestinal Microbiome, Humans, Intestinal Mucosa, Parkinson Disease, Research Design, Severity of Illness Index, Reproducibility of Results, Neuroimmunomodulation, Confounding Factors, Epidemiologic, Enteric Nervous System, Disease Progression, Evidence-Based Medicine, Neurodegenerative Diseases, Biomedical Research, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Methodical approach of systematic review due to PRISMA criteria (PRISMA criteria [33]).](https://figures.cochat.ai/paper-figures/9b939278a136418e9a3ebbc4669d8e86/changes-of-colonic-bacterial-composition-in-parkinson-s-disease-and-other-figure-1.jpg)